Immediate Impact
51 standout
Citing Papers
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Works of Minhao Fan being referenced
Emerging therapies for breast cancer
2017
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Minhao Fan | 304 | 174 | 133 | 265 | 11 | 526 | |
| Masaru Jida | 248 | 269 | 105 | 270 | 14 | 464 | |
| Johann Raats | 358 | 185 | 82 | 273 | 15 | 552 | |
| Andrea Ravelli | 284 | 198 | 105 | 246 | 15 | 533 | |
| Hielke J. Meulenbeld | 280 | 147 | 173 | 314 | 17 | 569 | |
| Rinat Galiulin | 367 | 135 | 108 | 385 | 7 | 550 | |
| Djamila Ouaret | 279 | 274 | 148 | 139 | 15 | 573 | |
| Tzu‐Hsiu Tsai | 367 | 182 | 174 | 461 | 17 | 596 | |
| Claus-Peter Schneider | 377 | 130 | 126 | 310 | 18 | 582 | |
| Roberta Bartolucci | 311 | 167 | 105 | 278 | 17 | 516 | |
| Teresa M. Hopper | 195 | 238 | 98 | 223 | 6 | 467 |
All Works
Login with ORCID to disown or claim papers
Loading papers...